AI Article Synopsis
Article Abstract
Objective: The primary aim was to investigate the role of underlying heart disease on preoperative NT-proBNP levels in patients admitted for adult cardiac surgery, after adjusting for the known confounders age, gender, obesity and renal function. The second aim was to investigate the predictive value of preoperative NT-proBNP with regard to severe postoperative heart failure (SPHF) and postoperative mortality.
Methods: A retrospective cohort study based on preoperative NT-proBNP measurements in an unselected cohort including all patients undergoing first time surgery for coronary artery disease (CAD; n = 2226), aortic stenosis (AS; n = 406) or mitral regurgitation (MR; n = 346) from April 2010 to August 2016 in the southeast region of Sweden (n = 2978). Concomitant procedures were not included, with the exception of Maze or tricuspid valve procedures.
Results: Preoperative NT-proBNP was 1.67 times (p<0.0001) and 1.41 times (p<0.0001) higher in patients with AS or MR respectively, than in patients with CAD after adjusting for confounders. NT-proBNP demonstrated significant discrimination with regard to SPHF in CAD (AUC = 0.79, 95%CI 0.73-0.85, p<0.0001), MR (AUC = 0.80, 95%CI 0.72-0.87, p<0.0001) and AS (AUC = 0.66, 95%CI 0.51-0.81, p = 0.047). In CAD patients NT-proBNP demonstrated significant discrimination with regard to postoperative 30-day or in-hospital mortality (AUC = 0.78; 95%CI 0.71-0.85, p<0.0001). The number of deaths was too few in the AS and MR group to permit analysis. Elevated NT-proBNP emerged as an independent risk factor for SPHF, and postoperative mortality in CAD.
Conclusions: Patients with AS or MR have higher preoperative NT-proBNP than CAD patients even after adjusting for confounders. The predictive value of NT-proBNP with regard to SPHF was confirmed in CAD and MR patients but was less convincing in AS patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805306 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192503 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Preoperative activation of the renin-angiotensin system and myocardial injury in noncardiac surgery: exploratory mechanistic analysis of the SPACE randomised controlled trial.
Br J Anaesth
December 2024
Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London, UK. Electronic address:
Background: Hypertension therapy in older adults is often suboptimal, in part because of inadequate suppression of the renin-angiotensin-aldosterone system (RAAS). We hypothesised that distinct endotypes of RAAS activation before noncardiac surgery are associated with increased risk of myocardial injury.
Methods: This was a prespecified exploratory analysis of a multicentre randomised controlled trial (ISRCTN17251494) which randomised patients ≥60 yr old undergoing elective noncardiac surgery to either continue or stop RAAS inhibitors (determined by pharmacokinetic profiles).
Background: Limited data from the literature are available to assess the efficacy of coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction. Therefore, our objective was to use machine learning techniques integrating clinical features, biomarker data, and echocardiography data to enhance comprehension and risk stratification in patients diagnosed with ischemic cardiomyopathy and heart failure with preserved ejection fraction who have undergone coronary artery bypass grafting surgery.
Methods And Results: For this study, 294 patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction who underwent coronary artery bypass grafting surgery were assigned to the development cohort (n=176) and the independent validation cohort (n=118).
[Platelet/white blood cell ratio in the prediction of postoperative acute kidney injury of patients].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
October 2024
Department of Intensive Care Unit, Honghui Hospital of Xi'an Jiaotong University, Xi'an 710054, Shaanxi, China. Corresponding author: Zhu Changliang, Email:
Objective: To investigate the risk factors and predictive value on acute kidney injury (AKI) following surgery, and to elucidate the relationship between platelet/white blood cell ratio (PWR) and AKI.
Methods: A retrospective case-control study was conducted. The patients who underwent surgery admitted to Honghui Hospital of Xi'an Jiaotong University from January 2019 to January 2023 were enrolled.
Diagnostic accuracy of NT-proBNP to predict the incidence of CSA-AKI: A systematic review and meta-analysis.
Medicine (Baltimore)
October 2024
Department of Cardiology, The Third Hospital of Mianyang/Sichuan Mental Health Center, Mianyang, Sichuan, China.
Article Synopsis
- CSA-AKI is a serious complication after cardiac surgery, and this study evaluates the effectiveness of NT-proBNP as a diagnostic tool for identifying at-risk patients.
- Researchers analyzed data from seven studies involving over 37,000 patients, finding that while higher NT-proBNP levels are associated with an increased risk of CSA-AKI, its overall sensitivity and specificity are not adequate for accurate prediction.
- The conclusion emphasizes the need for better biomarkers for the early detection of CSA-AKI, despite the insights gained on NT-proBNP's limitations.
[Cardiovascular management of patients undergoing noncardiac surgery].
Herz
December 2024
Kardiopraxis Schirmer, Am Altenhof 8, 67655, Kaiserslautern, Deutschland.
Article Synopsis
- Risk assessment for patients with cardiovascular diseases prior to noncardiac surgery is crucial due to the complexity of these cases and the need for multidisciplinary approaches.
- The assessment relies on factors like the type of surgery, the patient's cardiovascular health, and age, with preoperative consultations being less intensive when operation risks are low.
- Key evaluation tools include monitoring symptoms, exercise tolerance, and cardiac biomarkers like NT-proBNP and troponin, while existing cardiovascular medications should be maintained during surgery without new drugs being started.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!